- Home
- CHMI vs ANVS Comparison
CHMI vs ANVS Comparison
Compare CHMI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHMI | ANVS |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 111.3M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHMI | ANVS |
|---|---|---|
| Price | $2.52 | $3.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $2.75 | ★ $13.50 |
| AVG Volume (30 Days) | 228.8K | ★ 659.2K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 15.69% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $40,202,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $31.73 | N/A |
| P/E Ratio | $136.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.17 | $1.11 |
| 52 Week High | $3.68 | $5.60 |
Technical Indicators
Market Signals| Indicator | CHMI | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 44.27 |
| Support Level | $2.66 | $3.49 |
| Resistance Level | $2.78 | $3.72 |
| Average True Range (ATR) | 0.08 | 0.31 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 22.58 | 6.82 |
Price Performance
Historical ComparisonAbout CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.